Page last updated: 2024-08-26

cilastatin and Endocarditis, Bacterial

cilastatin has been researched along with Endocarditis, Bacterial in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (36.36)	18.7374
1990's	4 (36.36)	18.2507
2000's	1 (9.09)	29.6817
2010's	2 (18.18)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baba, H; Horimoto, K; Kubo, T; Matsusaka, H; Umesue, M	1
Joskowiak, D; Kappert, U; Matschke, K; Tugtekin, SM	1
Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z	1
Horstkotte, D; Klein, RM; Kramer, A; Niehues, R; Schaal, KP; Schlüter, S; Strauer, BE	1
Fichtenbaum, CJ; Smith, MJ	1
Hrdy, DB; Kailath, EJ; King, JH	1
Antonucci, G; Armignacco, O; Bordi, E; Bove, G; D'Amato, C; De Carli, G; De Mori, P; Rosci, MA; Visco, G	1
Chandrasekar, PH; Levine, DP; Price, S; Rybak, MJ	1
Cumberland, NS; Jones, KP	1
Alea, A; Arcey, S; Dickinson, G; Greenman, R; Rodriguez, K	1
Donabedian, H; Freimer, EH	1

Reviews

2 review(s) available for cilastatin and Endocarditis, Bacterial

Article	Year
Antimicrobial treatment of Capnocytophaga infections. International journal of antimicrobial agents, 2007, Volume: 29, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests	2007
Pathogenesis and treatment of endocarditis. The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A Topics: Animals; Cilastatin; Cyclopropanes; Disease Models, Animal; Endocarditis, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Thienamycins	1985

Article

Year

Antimicrobial treatment of Capnocytophaga infections.

International journal of antimicrobial agents, 2007, Volume: 29, Issue:4

Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests

2007

Pathogenesis and treatment of endocarditis.

The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A

Topics: Animals; Cilastatin; Cyclopropanes; Disease Models, Animal; Endocarditis, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Thienamycins

1985

Trials

1 trial(s) available for cilastatin and Endocarditis, Bacterial

Article	Year
The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections. Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:2 Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Urinary Tract Infections	1990

Article

Year

The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections.

Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:2

Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Urinary Tract Infections

1990

Other Studies

8 other study(ies) available for cilastatin and Endocarditis, Bacterial

Article	Year
Right-sided infective endocarditis with a ruptured sinus of Valsalva and multiple septic pulmonary emboli in a patient with atopic dermatitis. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:7 Topics: Adult; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Dermatitis, Atopic; Drug Combinations; Endocarditis, Bacterial; Female; Gentamicins; Heart Failure; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Sinus of Valsalva; Treatment Outcome; Tricuspid Valve	2015
Ruptured pulmonary artery caused by isolated pulmonary valve endocarditis: case report. Clinical research in cardiology : official journal of the German Cardiac Society, 2010, Volume: 99, Issue:7 Topics: Aged; Aneurysm, Ruptured; Anti-Bacterial Agents; Anti-Infective Agents; Carcinoma, Hepatocellular; Cilastatin; Ciprofloxacin; Endocarditis, Bacterial; Fatal Outcome; Hepatectomy; Humans; Imipenem; Liver Neoplasms; Male; Protease Inhibitors; Pulmonary Artery; Pulmonary Valve; Rupture, Spontaneous; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2010
[Systemic Nocardia asteroides infection with endocardial involvement in a patient undergoing immunosuppressive therapy]. Deutsche medizinische Wochenschrift (1946), 1996, Nov-08, Volume: 121, Issue:45 Topics: Anti-Bacterial Agents; Brain Diseases; Cilastatin; Cyclosporine; Doxycycline; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Eye Infections, Bacterial; Fatal Outcome; Humans; Imipenem; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Nocardia asteroides; Nocardia Infections; Pneumonia; Protease Inhibitors; Status Epilepticus; Thienamycins	1996
Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Pseudomonas Infections; Tobramycin	1992
Successful use of higher-than-recommended dosage of imipenem in Pseudomonas aeruginosa endocarditis. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:5 Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Pseudomonas Infections; Risk Factors; Tobramycin	1992
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1988, Volume: 21, Issue:4 Topics: Animals; Aortic Valve; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Endocarditis, Bacterial; Heart Valve Diseases; Imipenem; Methicillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin	1988
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin. Journal of the Royal Army Medical Corps, 1987, Volume: 133, Issue:3 Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection	1987
Efficacy of imipenem/cilastatin in endocarditis. The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A Topics: Adult; Aged; Bacteria; Cilastatin; Cyclopropanes; Drug Combinations; Endocarditis, Bacterial; Humans; Imipenem; Middle Aged; Staphylococcal Infections; Thienamycins; Time Factors	1985